Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...

In the United States and elsewhere, there’s been a major shift in patients treated for lung cancer. As the percentage of ...

Applicants to a prestigious National Science Foundation fellowship program say many submissions have been mysteriously ...

The director-general of the WHO said a U.S.-funded study of the hepatitis B vaccine in Guinea-Bissau would be “unethical” if ...

The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

So: Moderna says it was blindsided by the FDA, and Vinay Prasad, on its mRNA flu vaccine. Meanwhile, regulators are moving ...

I’m a practicing clinical psychologist, and over the past year, I have begun using a conversational AI tool as part of my ...

To reduce heart disease risk, it's the quality, not the quantity, of carbs or fats that matter, says new study from the ...

As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.

The Trump admin is reframing steep Medicaid cuts to pit states with large urban centers against those with large rural populations.